Joint association of remnant cholesterol and lipoprotein-associated phospholipase A2 with composite adverse events: A 12-year follow-up study from Asymptomatic Polyvascular Abnormalities Community study.

Diabetes Obes Metab · 2025 · PMC11964985 · PMID 40035211

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results indicate that the high‐RC/Lp‐PLA2+ group showed a trend toward an increased risk of the composite endpoint compared to the low‐RC/Lp‐PLA2− group, although this association did not achieve statistical significance ( p interaction = 0.081 and 0.677, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.